Key Details
Price
$9.42Last Dividend
$1.90Annual ROE
-30.85%Beta
-0.05Events Calendar
Next earnings date:
Feb 6, 2025Recent quarterly earnings:
Dec 12, 2024Recent annual earnings:
Dec 12, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Jul 12, 2005Next split:
N/ARecent split:
Dec 8, 2016Analyst ratings
Recent major analysts updates
Market Data
Price
Market cap
Technical
Dividend
Events
Dividend per share
Dividend yield
Other
Profitability
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Liquidity
Leverage
Risk & Stability
Balance Sheet
Assets
Equity
Liabilities
Debt
Expenses
Cash Flow
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
LAS VEGAS, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (Nasdaq: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, today announced financial results for its fiscal first quarter 2025 ended December 31, 2024.
LAS VEGAS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (NASDAQ: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, will issue its financial results for its fiscal first quarter ended December 31, 2024, before the market opens on Thursday, February 6, 2025. The Company will hold a conference call to discuss the results on Thursday, February 6, 2025, at 2:00 p.m. Pacific Standard Time (5:00 p.m. Eastern Standard Time).
ISELIN, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) earlier this year for the first authorized use of an ophthalmic formulation of bevacizumab for the treatment of wet age-related macular degeneration (wet AMD), today announced that Lawrence A.
Live webcast on Wednesday, January 29 th at 2:40 PM ET PRINCETON, NJ, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced that Pankaj Mohan, Ph.D., Chief Executive Officer of Sonnet will present at LIVE!
Live Ventures Incorporated (NASDAQ:LIVE ) Q4 2024 Earnings Conference Call December 12, 2024 5:00 PM ET Company Participants Greg Powell - Director of Investor Relations David Verret - Chief Financial Officer Jon Isaac - President and Chief Executive Officer Conference Call Participants Joseph Kowalsky - JD Investments Operator Welcome to the Live Ventures Fiscal Year 2024 Year-End Earnings Conference Call. At this time, all participants are in a listen-only mode.
LAS VEGAS, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (NASDAQ: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, will issue its financial results for its fiscal year ended September 30, 2024, before the market opens on Thursday, December 12, 2024. The Company will hold a conference call to discuss the results on Thursday, December 12, 2024, at 2:00 p.m. Pacific Standard Time (5:00 p.m. Eastern Standard Time).
YANGZHOU, China , Aug. 26, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced that Xin "Steven" Wang, Chief Executive Officer of Meihua, will present and discuss recent corporate events at LIVE!
Live Ventures Incorporated (NASDAQ:LIVE ) Q3 2024 Earnings Call August 8, 2024 5:00 PM ET Company Participants Greg Powell - Director, Investor Relations Jon Isaac - Chief Executive Officer and President David Verret - Chief Financial Officer Conference Call Participants Joseph Kowalsky - JD Investments Operator Welcome to the Live Ventures FY 2024 Third Quarter Earnings Conference Call. [Operator Instructions] I would now like to turn the call over to Greg Powell, Director of Investor Relations.
LAS VEGAS, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (NASDAQ: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, will issue its financial results for its fiscal third quarter ended June 30, 2024, before market open on Thursday, August 8, 2024. The Company will hold a conference call to discuss the results on Thursday, August 8, 2024, at 2:00 p.m. Pacific Daylight Time (5:00 p.m. Eastern Daylight Time).
LAS VEGAS, June 13, 2024 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (Nasdaq: LIVE), a diversified holding company (“Live Ventures” or the “Company”), today announced that its subsidiary, Flooring Liquidators, Inc. (“Flooring Liquidators”) has opened a 60,000 square foot store in Springfield, Missouri. This branded Flooring Liquidators store is its largest store and will serve as a distribution center for its future stores in the Midwest, as well as its branded Gary's Floor and Home stores in Arkansas. At this new location, customers can shop from a full line of laminate, carpet, hardwood, natural stone and ceramic tile, luxury vinyl tile flooring, and a range of quality countertops.
FAQ
- What is the ticker symbol for Live Ventures Incorporated?
- Does Live Ventures Incorporated pay dividends?
- What sector is Live Ventures Incorporated in?
- What industry is Live Ventures Incorporated in?
- What country is Live Ventures Incorporated based in?
- When did Live Ventures Incorporated go public?
- Is Live Ventures Incorporated in the S&P 500?
- Is Live Ventures Incorporated in the NASDAQ 100?
- Is Live Ventures Incorporated in the Dow Jones?
- When was Live Ventures Incorporated's last earnings report?
- When does Live Ventures Incorporated report earnings?
- Should I buy Live Ventures Incorporated stock now?